Literature DB >> 24866239

A pyrene based fluorescence approach to study conformation of apolipoprotein E3 in macrophage-generated nascent high density lipoprotein.

Sea H Kim1, Shweta Kothari1, Arti B Patel1, John K Bielicki2, Vasanthy Narayanaswami3.   

Abstract

Apolipoprotein E3 (apoE3) is an anti-atherogenic apolipoprotein with the ability to exist in lipid-free and lipoprotein-associated states. During atherosclerosis, its function in promoting cholesterol efflux from macrophages via the ATP-binding cassette transporter A1 (ABCA1) takes a prominent role, leading to generation of nascent high density lipoprotein (nHDL) particles. The objective of this study is to understand the conformation adopted by apoE3 in macrophage-generated nHDL using a fluorescence spectroscopic approach involving pyrene. Pyrene-labeled recombinant human apoE3 displayed a robust ability to stimulate ABCA1-mediated cholesterol efflux from cholesterol-loaded J774 macrophages (which do not express apoE), comparable to that elicited by unlabeled apoE3. The nHDL recovered from the conditioned medium revealed the presence of apoE3 by immunoblot analysis. A heterogeneous population of nHDL bearing exogenously added apoE3 was generated with particle size varying from ∼12 to ∼19 nm in diameter, corresponding to molecular mass of ∼450 to ∼700 kDa. The lipid: apoE3 ratio varied from ∼60:1 to 10:1. A significant extent of pyrene excimer emission was noted in nHDL, indicative of spatial proximity between Cys112 on neighboring apoE3 molecules similar to that noted in reconstituted HDL. Cross-linking analysis using Cys-specific cross-linkers revealed the predominant presence of dimers. Taken together the data indicate a double belt arrangement of apoE molecules on nHDL. A similar organization of the C-terminal tail of apoE on nHDL was noted when pyrene-apoEA277C(201-299) was used as the cholesterol acceptor. These studies open up the possibility of using exogenously labeled apoE3 to generate nHDL for structural and conformational analysis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apolipoprotein E3; Cross-linking; Macrophage; Nascent HDL; Pyrene fluorescence; Reverse cholesterol transport

Mesh:

Substances:

Year:  2014        PMID: 24866239      PMCID: PMC4130211          DOI: 10.1016/j.bbrc.2014.05.071

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E.

Authors:  C Wilson; M R Wardell; K H Weisgraber; R W Mahley; D A Agard
Journal:  Science       Date:  1991-06-28       Impact factor: 47.728

2.  Structural determination of lipid-bound ApoA-I using fluorescence resonance energy transfer.

Authors:  H Li; D S Lyles; M J Thomas; W Pan; M G Sorci-Thomas
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

3.  Lipid association-induced N- and C-terminal domain reorganization in human apolipoprotein E3.

Authors:  V Narayanaswami; S S Szeto; R O Ryan
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

Review 4.  Apolipoprotein E: far more than a lipid transport protein.

Authors:  R W Mahley; S C Rall
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

5.  The spatial organization of apolipoprotein A-I on the edge of discoidal high density lipoprotein particles: a mass specrometry study.

Authors:  W Sean Davidson; George M Hilliard
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

6.  Helix orientation of the functional domains in apolipoprotein e in discoidal high density lipoprotein particles.

Authors:  Vasanthy Narayanaswami; J Nicholas Maiorano; Padmaja Dhanasekaran; Robert O Ryan; Michael C Phillips; Sissel Lund-Katz; W Sean Davidson
Journal:  J Biol Chem       Date:  2004-01-21       Impact factor: 5.157

Review 7.  The low-density lipoprotein receptor: ligands, debates and lore.

Authors:  Gabby Rudenko; Johann Deisenhofer
Journal:  Curr Opin Struct Biol       Date:  2003-12       Impact factor: 6.809

8.  Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.

Authors:  G Ghiselli; E J Schaefer; P Gascon; H B Breser
Journal:  Science       Date:  1981-12-11       Impact factor: 47.728

9.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

Authors:  S H Zhang; R L Reddick; J A Piedrahita; N Maeda
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

10.  Mechanisms responsible for the compositional heterogeneity of nascent high density lipoprotein.

Authors:  Sissel Lund-Katz; Nicholas N Lyssenko; Margaret Nickel; David Nguyen; Palaniappan Sevugan Chetty; Ginny Weibel; Michael C Phillips
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

View more
  3 in total

1.  Conformational analysis of apolipoprotein E3/E4 heteromerization.

Authors:  Kai-Han Tu; Devan Abhari; Vasanthy Narayanaswami
Journal:  FEBS J       Date:  2019-03-13       Impact factor: 5.542

2.  Cellular Uptake and Clearance of Oxidatively-modified Apolipoprotein E3 by Cerebral Cortex Endothelial Cells.

Authors:  Siobanth Cruz; Vasanthy Narayanaswami
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

Review 3.  Reconfiguring Nature's Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents.

Authors:  Skylar T Chuang; Siobanth Cruz; Vasanthy Narayanaswami
Journal:  Nanomaterials (Basel)       Date:  2020-05-08       Impact factor: 5.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.